Dr. Dean Kereiakes and Dr. C. Michael Gibson Discuss: First Human Study of a Novel Platelet Glycoprotein IIB/IIIA Inhibitor Designed for Point of Care ST-Segment Myocardial Infarction Treatment November 16, 2019 2019 | AHA | Cardiology Tags: 2019, AHA, Cardiology http://tv.clinicaltrialresults.org/file_repos/85/2413-2385.mp4 Download Disclosures: TBA Article Navigation Dr. John McMurray and Dr. C. Michael Gibson Discuss: DAPA-HF: The Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure Trial (DAPA-HF): Results in Nondiabetic Patients Dr. Carolyn Lam and Dr. C. Michael Gibson Discuss: Role of AI and Machine Learning in Cardiac Imaging and Beyond
